FDA Ex-U.S. Trial Filings Will Need “Explicit” Good Clinical Practice Info
Executive Summary
FDA is moving toward requiring more "explicit" information on good clinical practice procedures for non-U.S. trials, Senior Advisor for Clinical Science David Lepay, MD/PhD, said at the Drug Information Association EuroMeeting in Prague March 13